Karnataka: Shivamogga Doctor Dies; Govt Says Not Linked To Vaccine

BENGALURU : A 58-year-old doctor from Shivamogga died on Wednesday, two days after he was given Covishield vaccine. The Union health ministry’s report on Adverse Effects Following Immunisation said the death was due to cardiac problems. District health officer Rajesh Suragihalli said the death of Dr Jayaprakash TA, who was with Subbaiah medical college hospital, is not linked to the vaccination drive.

He developed severe chest pain in the early hours of Wednesday and was admitted to a private hospital where he died hours later, said Dr SM Katti, principal of the medical college. District health officer Dr Rajesh Suragihalli told TOI: “He died due to cardiac problems. He had been suffering from heart-related issues for some time now. His death is not related to the vaccine drive, which is also confirmed by the Union health ministry. After taking vaccination, he had shared his pictures on social media and requested frontline warriors to come forward.”

Jayaprakash’s wife, a gynaecologist who works in Shivamogga, and two daughters are away in the US. Katti said the doctor suffered a cardiac arrest and the death is not linked to the vaccine.

Pankaj Kumar Pandey, commissioner, health and family welfare department, said the doctor had conducted classes after his vaccination and was doing well after taking the jab. “It is learned that he was highly diabetic and had undergone bypass surgery earlier. The reports say that he has died due to cardiac arrest,” he said.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit